Filing Details

Accession Number:
0001493152-21-025348
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-13 19:08:46
Reporting Period:
2021-10-11
Accepted Time:
2021-10-13 19:08:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
318306 Abeona Therapeutics Inc. ABEO Pharmaceutical Preparations (2834) 830221517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1884342 M. Brendan O'malley 1330 Avenue Of The Americas, 33Rd Floor
New York NY 10019
Svp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-10-11 25,734 $0.90 222,510 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading planadopted by Brendan O'Malley on February 24, 2021.
  2. The price reported in Column 4 is a weighted average price. The shares weresold in multiple transactions at prices ranging from $0.89 to $0.9625, inclusive.The reporting person undertakes to provide to the Issuer, any security holder,or the Staff of the SEC, upon request, full information regarding the number ofshares disposed at each separate price within the ranges set forth in thisfootnote.